title: Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.
authors.forename: Kalliopi
authors.initials: K
authors.lastname: Zachou
authors.forename: George N
authors.initials: GN
authors.lastname: Dalekos
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006509:Hepatitis B; D006515:Hepatitis B virus / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000821:virology*; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000009:adverse effects*; D008403:Mass Screening; D000069283:Rituximab; D014775:Virus Activation / Q000187:drug effects* / Q000276:immunology
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000069283:Rituximab